All posts by student

Nominations open for the PLOS Genetics Research Prize 2017 – PLoS Blogs (blog)

Have you read a 2016 PLOS Genetics Research Article that stood out for you in terms of the strength of its analysis or impact on your field? Maybe you edited or reviewed a manuscript that caught your attention? If so, you may want to nominate it for the PLOS Genetics Research Prize 2017!

Now entering its third year, the prize awards $5,000 to the authors of the winning Research Article, selected by the PLOS Genetics Editors-in-Chief and Senior Editors from a pool of public nominations, based on the criteria of scientific excellence and community impact. Previous winners were Barroso-Batista, Sousa et al. for The First Steps of Adaptation of Escherichia coli to the Gut Are Dominated by Soft Sweeps in 2015, and in 2016, Naranjo, Smith et al. for Dissecting the Genetic Basis of a Complex cis-Regulatory Adaptation.

To tell us which 2016 Research Article you think is worthy of this award, please complete our nomination form. Nominations are open to the public until Friday June 16, 2017 at 11:59 PM ET.

For more information on the Prize, take a look at the Program Page and Program Rules. Questions about the Prize can also be sent to plosgenetics@plos.org.

Featured image credit: December 2016 Issue Image. Immunofluorescent staining of 2-month-old ovarian sections. Image Credit: Meng-Wen Hu

Read more here:
Nominations open for the PLOS Genetics Research Prize 2017 - PLoS Blogs (blog)

Harvard’s Pamela Silver recalls journey from Silicon Valley to synthetic biology – Harvard Gazette

Life stories from Annette Gordon-Reed, Martin Karplus, Joseph Nye, E.O. Wilson, and many more, in the Experience series.

In 1960s Silicon Valley Pamela Silver came of age part math nerd, part rebel, absorbing the spirit of both time and place. Think space race. Think Grateful Dead.

She set out on her scientific career without a plan, propelled by an aptitude for math, an interest in science, and a love of the sometimes frenzied life of the laboratory. That love fueled groundbreaking work on how proteins make their way from the cytoplasm of a cell into the nucleus, a process called nuclear localization. Decades and many discoveries later, the same passion helped establish her as a leader in the fledgling field of synthetic biology.

Silver was recently named a fellow of the American Academy of Arts and Sciences. She is the Elliot T. and Onie H. Adams Professor of Biochemistry and Systems Biology.

Q: Lets start at the beginning. You grew up in Atherton, Calif., in Silicon Valley?

A: [My parents] were both psychotherapists, and it made for an interesting childhood. I think they must have met here [in Boston] and then they moved to the Bay Area probably right after the war, late 40s, early 50s. And my father became one of the founders of the Palo Alto Medical Clinic; it was one of the first group practices, sort of soup-to-nuts. [He] was also on the Stanford faculty. They moved to California right at the beginning of the rapid growth of Silicon Valley. We lived in Atherton before it was the richest town in the world. It was kind of cool, these old estates, built by James Flood and his children big mansions and big land. They were just starting to subdivide it. Our house was one of the first ranch-style homes. It was already kind of upper class, but I didnt realize that at the time; it was just where we lived.

Q: You never do when youre a kid. You just grow up in your surroundings.

A: The roads were still dirt. The Flood granddaughters still lived there and had horses, so we could walk around and feed the horses. It all seemed very idyllic to me, I guess if I think back on it, which I do more and more. My parents were very high-level thinkers and very intelligent. That obviously set the tone in our household, maybe a little overdoing it. My sister was actually 10 years older, so it was more like I was an only child.

Q: Is your sister your only sibling?

A: Yes. My parents did get divorced. We were not a tightknit family but more highly dysfunctional. And in retrospect that was OK in terms of my own independence and things like that.

At that time in Silicon Valley, everything was very science-oriented. How do we promote science in schools it was all about the space race and stuff like that. I apparently had precocious math ability. Some on my fathers side of the family had an inclination to mathematics. He nurtured this. He taught me how to play Go when I was 6. Chess, maybe, but Go? Really?

I won an IBM math contest when I was in junior high, but nobody was pushing me. My parents were so preoccupied with themselves, they just wanted to make sure that I didnt do anything bad.

Q: I read that you got a slide rule as a prize?

A: Yeah, that was the prize. What a hoot. It wasnt just any slide rule. My slide rule had a beveled edge, so the slider thing was here and you could still use it as a straight edge. What an amazing slide rule. Ive never been able to find one like it. I also loved homework. I would beg the teachers in elementary school to give me homework, partly because I think it was a way to get lost from the family dysfunction and also it was just interesting.

Q: What about your early schools?

A: I went to the public high school, which was nearby, for a year. Then my parents sort of decided that I wasnt getting the right education. They sent me to a local all-girls high school called Castilleja. Its one of the few all-girls high schools left. It didnt seem to emphasize science very much. The times were very disruptive. There was a lot of protest and the Vietnam War, and there you are in the all-girls school. It was a bit odd.

Q: You said it wasnt heavy on science. Was your interest in

A: My interest was independence. I have to say I was kind of a wild kid in high school. Lets be honest, there was a fair amount of recreational drug-taking and going to the Fillmore Auditorium I was heavily into the music of the times. The Grateful Dead were still kind of a local band and we were big fans it was a big part of the local culture. Bob Weir grew up nearby, and they used to practice locally. Even when we were kids, we would go listen to them. They would play at local parks and pizza parlors.

The great thing about my school is that the teachers took a personal interest in me. I had one teacher that thought I was a good writer. No idea why. The Palo Alto Times the school was in Palo Alto would have a student from each school write columns, and so she assigned me to be the reporter for Castilleja. So I really got into that. Then there was this whole culture around personal computers and electronic hacking. There were so many wacky things going on, and even as teenagers we were very much part of that. Not clear how the parents felt about it.

Q: What about college?

Castilleja was very much a college prep school. I applied to Stanford and Yale, but my real top choice was UC Santa Cruz, which is where I ended up going. I knew from the start that I wanted to do science, so the other good thing was that there werent very many course requirements or grades. I took as many advanced placement tests as possible, so I wouldnt have to take anything but science classes, which probably made my whole undergraduate experience very warped. I started as a math major, maybe, then went to physics, and then ended up in chemistry. One thing I wanted to do, which Santa Cruz was very big on, was independent research, and so as fast as possible I just wanted to get into that, and I did.

Q: Where did your initial interest in science come from?

A: I would say its a combination of this uber-intellectual family life and also the school system, for sure. There were science contests and endless science projects, and my father fed that a little bit. I remember, in first grade, he brought a dissected cat to the class, because he was an M.D. Hed take me to the hospital all the time. A lot of our family friends were somehow connected to either the medical or engineering [fields]. My father used to play poker with [Nobel Prize-winning chemist] Linus Pauling, and one of my first job interviews in high school was at his institute. Other fathers gave me early programmable personal calculators for homework.

Q: So, youre in college, and youre wending your way from math to physics to chemistry. How did that go?

A: The math part I dont remember much about. Physics was transient also. What I realized about myself was that I wanted to do experiments. So I think I ended up in chemistry because of the opportunity to do experiments. Im sure it was a product of people I met and knew and things like that teachers but also I always was kind of a rebel. Everyone was majoring in psychology, that was the thing. There was just no way I was going to do what everyone else did.

Q: No temptation, given your parents background?

A: Absolutely none. Zero. Med school off the table. Forget it. College was meeting up with just crazily interesting people. And Santa Cruz was just idyllic. Youd go off in the woods and the trees and surfing oh, and sailing. Big deal, sailing. Probably the one thing that I got out of that was being on the sailing team and having something organized in my life. So that was different and fun.

Our whole goal was to make the engineering of biology faster, cheaper, and more predictable. Lets say we succeed. So then what? Do we have the perfect planet? Is everything wonderful? Is there misuse? Im thinking about things I dont know the answer to.

Q: Are you still a sailor?

A: Yeah, its [in the picture] right behind you. Thats my boat.

Mostly I worked in the lab a lot. I liked the lab culture. I liked the all-night thing and feeling like you belonged and you were working on something. I really liked that part of it. I just characterize my life as not having a plan. And people say to me: But youre at Harvard, howd that happen? It just kind of happened. Im not saying that was a good thing or a bad thing, but I do compare it to these kids now who start out so early with a plan. I am glad I had time to explore and be kind of a dreamer.

So college is ending. I heard about this graduate school thing, and maybe I should apply. Id heard of two chemistry programs that I thought would be, for some reason, good. One was Berkeley and one was Harvard. Those were my only two grad school applications. I remember somehow deciding that I didnt want to go to grad school, though. I forget why. My father had died. I just didnt feel right. I had no money, and so I decided, maybe Ill just get a job. It was all complicated with boyfriends and husbands and lots of stuff. I did get a job at a startup chemical company, literally in Silicon Valley. It was across the street from Hewlett-Packard, really in the thick of it.

Q: So how did you end up going back to graduate school?

A: With my then-spouse, I moved to Los Angeles. The short story is thats how I ended up going to UCLA for grad school. Id actually spent an extra year at Santa Cruz doing this protein structure work, so I bargained with UCLA. If I could pass the equivalent of their qualifying exam, could I not take any classes and therefore finish my Ph.D. as fast as possible? I passed it, and so I got my Ph.D. in three years. I had a very supportive adviser who said you should just get your Ph.D. really fast. It was a good experience.

Q: How was choosing Harvard for a postdoc different from not choosing it for grad school?

A: Maybe there was finally an element of careerism starting to emerge. All these guys at UCLA were super young hotshots, and they had all come from Stanford and Harvard. So there was probably an element of hey, I can do that.

At the same time, my adviser kept trying to push me, which just was perfect for me. He kept saying, try to do something where you set up your own research program. I did formulate a question in my mind of what I thought I wanted to solve. That was the question of how do things proteins and RNAs move between the nucleus and the cytoplasm? I had some hypotheses about this, so I approached a couple of faculty here.

One was well known for letting people come to do whatever they wanted, so I went there. But I spent the summer before at Cold Spring Harbor. I went there to take the yeast course, which was a big deal then. That was just a total eye-opener.

Q: Learning how to manage and use yeast as an experimental organism, essentially?

A: Yes, but it was also about learning how to think as a geneticist, and it was just transformative for me. In many ways being at Cold Spring Harbor was amazing. Being in this community of scientists where it had that kind of 24-hour science-is-the-big-thing, interesting people to talk to left and right. Id never seen anything like it. Youre just kind of away from all your responsibilities. It was just very magical and crazy, and I thought, jeez, this is how it should be.

So when I got back to Boston, I started working in the lab Id chosen. And I met people in Mark Ptashnes lab, which was kind of a happening place. There was a lot of energy.

I realized that I was initially not in the right lab nothing wrong with it, it just wasnt right for me. So I went to Mark, and I said, I have this idea, and Ive thought more about it. I think I could test it better using yeast. And he was starting up this yeast group. So I joined Marks lab, and it was an amazing experience. The people there were just insanely smart. I mean, there were ups and downs, for sure, and some of those people could fight like dogs. It was either politics or science. It was just a crazily intense environment and I solved my problem. I discovered how proteins have a sequence that targets them into the nucleus, and that was one of the first examples of that. And I really did it on my own.

[At the end of the postdoc] everyone else seemed to have a plan. I said, hey, if this whole nuclear localization thing doesnt work out, Ill do something else. I did not have the Im-going-to-be-a-professor-for-sure mentality at all. I remember picking a couple schools that I thought I might actually go to if they offered me jobs, places that had openings. It was a very short list. One was Harvard. And one was Yale. One was Princeton. And one was Cornell.

I had interviews everywhere. I did not think about gender bias back then. I really did not. There were times I realized in college I was the only woman in the class. I just never felt anything [sexist] until I went on those job interviews and there were almost no women faculty mostly dinners with all guys. Then I had an offer at Princeton. And then at Yale. Princeton was sort of: Were growing, were new. And I thought, well, that sounds interesting. And I went to Princeton but did not stay for long.

Q: You went to Dana-Farber Cancer Institute and were there for a while, right?

A: Yeah. I was hired in BCMP [Biological Chemistry and Molecular Pharmacology], and Chris Walsh was the chair. And he essentially saved my scientific life. I always say they took a risk on me. Many people said something like, Oh my God, youre going to go to Harvard? Theyre so mean. Its going to be horrible. It was the antithesis of all those things super-supportive and they wanted me.

Q: So you were here as an associate professor?

A: Based at Dana-Farber. My full appointment was in BCMP. It was back in the old days, when getting tenure took forever. The agreement was that when I was hired, they would start the process. And back then, the process sometimes took two to three years. So I had to sweat it a bit, but I had good friends there and good support. Ive been blessed with regard to funding for my research, so far. I was worried being at Dana-Farber would be odd for me as a basic scientist, but it turned out it was fabulous. I was worried I wouldnt get grad students. That turned out not to be true got great students, great postdocs. And I continued to work on cell biology combined with molecular biology, and then it expanded into what you loosely might call systems biology.

And my work had some cancer overtones to it in that we did discover we did a small molecule screen where we discovered small molecules where, in principle, we could decipher the mechanism by which they would revert cancer cells away from cancer.

Q: How did you transition from Dana-Farber to what was then the new Department of Systems Biology at Harvard Medical School?

A: My own research was transitioning. I was taking a more systems-wide view of the cell biological problems I was working on. And also I was starting to feel like it was a time in my life where I was looking to change.

It was a really good time for Dana-Farber. They were starting to get a handle on making targeted drugs for cancer, the kinase inhibitors. And I felt good about Dana-Farber, that they were going in a good direction, that they were closer to real cancer cures. But I wasnt sure that my work was still a good fit. It had been so I mean that in a positive way.

The other thing that happened that was probably more consequential was that my now-husband, Jeff Way, who works here at the Wyss Institute, was helping a friend of ours start a new institute in Berkeley. He met a young postdoc there named Drew Endy and they became good friends. Drew had come from civil engineering, I think, and [he was] thinking about where biology should go. And then he came here this was in the early 2000s, late 1990s and started this group at MIT. It was bioengineers, computer scientists, and included me as the token real biologist. And that became the Synthetic Biology Working Group.

It was nearby, so I could go over there a lot. I became pretty engaged in that. Then, simultaneously, Marc Kirschner [of Harvard] was starting this new department [of systems biology]. Marc asked me if I wanted to be part of this department.

Q: And this was in around 2004, right?

A: Right. It was fun to be around new people, new ideas, and also I was given the charge of starting the new grad program.

Q: Lets talk about the grad program and your thoughts on graduate education.

A: Ive had a ton of grad students, and I watched them matriculate and turn into scientists. Id been thinking a lot about it and what that meant, and also this engagement with MIT was giving me a different perspective. One idea was it shouldnt be that you come to grad school and just take a bunch of classes. You come to grad school to do research. They should engage in research soon and they would get custom mentoring. Also, we tried to attract students from a diversity of areas. They could come from computer science or math. So they didnt necessarily have to have a biology background.

The other thing I encouraged was collaborative projects, so you could have, for example, two advisers. A lot of students took us up on that. That would increase collaboration amongst the faculty through the students.

It goes to the idea that the students are empowered and theyre helping define their education. It was about getting a mix of faculty across the University from different disciplines, not just the Medical School. Have a big umbrella. I liked that component of it. We got a significant number of applicants, and they were just amazing; they were some of the top students in the country. And then it stayed that way, and we got these interesting, quirky students. Im not running it anymore. Its still a great program.

Q: During this period, you were starting to focus more on synthetic biology, right?

A: Right.

Q: So tell me a little bit about that. You were at the meetings at MIT. Were you coming to understand the potential of looking at biology as modular, that it could be engineered in a rational way once you figured it all out?

A: The modularity of biology was something that resonated for me, because it was the essence of much of my work in molecular biology. I had done things like take parts of proteins and fuse them to other proteins and show they could move to the nucleus in the cell. So thats one essence of modularity. I was primed to think about it that way. I dont know if I called it synthetic biology or anything, but it was very much in my wheelhouse.

Q: Lets talk about your lab. What do you consider milestones?

A: Well, the first one was programming yeast to sense radiation. You can build sensors, but we wanted to build cells that not only sensed, but remembered. That was one of our first successes: building predictable circuits in yeast.

Q: How do you get a cell to remember?

A: There are a lot of different ways. Our way was to use transcriptional control, which is regulating how genes are made. One theme of our research is to draw from what we know about nature and try to apply that to practical problems. What nature tends to do with transcription is to use different kinds of feedback control that can either be positive or negative. So we took advantage of that. If you have a signal, instead of just having one burst, [we engineered it to] keep itself going, so it has this continuous feedback control. Thats a process used by nature that we deployed in our work.

Q: So exposure to radiation would trigger a process that

A: Yes. Imagine it triggers a pulse and something happens, and then that promotes a more sustained response over time.

Q: And that sustained response is the memory?

A: We call that the memory, yes. Memory of course means a lot of things to a lot of people, especially in neurobiology. So were using the term memory in a loose way here.

Q: And without this, the cell would respond and then stop?

A: And stop, yes.

Q: So youd be able to look at it and say, since this process is ongoing, something happened in

A: That it happened sometime in the past. My overall dream, which I think were close to achieving, is not only would something happen in the past, but a cell then could count and tell you when it happened, so it would be a true computer. And it would tell you when it happened and then ultimately do something. That doing of something, hopefully, could be something practical, like emit a signal that tells you there are poisonous chemicals somewhere or that theres a pathogen, or produce a therapeutic on-demand at the right time. We havent gotten there, but, at the time of me getting involved in synthetic biology, that was the overarching dream. Now weve taken a lot of different side paths.

We have this paper coming out in a few weeks about sensing inflammation in the gut. That, of course, is a huge problem in general. Theres no good treatment and its a chronic disease. Many people suffer from it. So we can create intestinal bacteria that will report on inflammation. Now the question is, can we get them to make a therapeutic for it? Thats one of the examples of the dream getting close to reality.

Q: Another project youve worked on is the bionic leaf.

A: Its super exciting. There are just so many opportunities here at Harvard, sometimes you look back and you say, oh my God, this thing happened. I was working on cyanobacteria, which are one of the simplest organisms that do photosynthesis, and we had engineered them to make hydrogen. We were believers in the hydrogen economy, which kind of didnt turn out so well. It might come back someday.

I got invited to be part of the Harvard University Center for the Environment, and Dan Schrag, the director, introduced me to Dan Nocera at the holiday party. Dan Nocera he had just moved [to Harvard], and he said something like, Ive been trying to meet you. Ive got this artificial leaf. It makes hydrogen. And I responded with, Ive got these bacteria, and theyll eat hydrogen and fix CO2. It was like two synergistic personalities; it just clicked.

Q: Looking ahead in synthetic biology 10 years from now what do you think will be most important?

A: In the perfect world, I would say on-demand drugs would be a big deal, whether that be protein-based drugs, cell-based drugs, or chemicals. For example, a friend of mine who is a professor at Stanford has made yeast that will make opiates. Think about the consequences of that. One is economic and the other is to make designer opiates that get rid of some of the bad things about them. I think thats just an example of the power of biology to make things weve never seen before.

We are at a tipping point around DNA synthesis. Its not yet cheap enough where a grad student could say, Im going to build a whole new organism. We need another kind of technological leap.

Our whole goal was to make the engineering of biology faster, cheaper, and more predictable. Lets say we succeed. So then what? Do we have the perfect planet? Is everything wonderful? Is there misuse? Im thinking about things I dont know the answer to. How do you find the genetically engineered organisms [released into the environment]? How do you respond quickly to a pandemic? These are things I think we are poised to do well. Can we make a vaccine in a day? Can we figure out what a pandemic is in a few hours? That really fits the bill of faster, cheaper.

How do we marry the coming firestorm of AI with synthetic biology? There was a time when young people wanted to work on molecular biology. That was the cool thing. AI is the cool thing now. Hundreds of undergrads at MIT want to take Intro AI. So we have to capture that imagination and meld it with synthetic biology.

Q: Do you look at young women in science today and think about how things are either different or the same as when you were coming up?

A: There are still a lot of males in charge and, as you get higher up the food chain, you start to notice different things. There are still times Im the only woman in the room. I have my one activism thing, where if I see meetings with no women speakers, I write a letter. I have some things that I call out, like science advisory boards with no women. So I make a pest of myself every now and then, but so do a lot of other people.

But about the trainees that is something I think were all worried about. Its a complicated problem. It feels like its harder to get women applicants and have them stick with it. I try to encourage the women in my own group. But at the same time, they have to make choices that make them happy. There just still arent a lot of women at the top. How much impact does it have if youre a younger woman and you dont see women in [leadership]?

If Harvard holds a symposium, it should never be all male. Any topic theres no reason. These, to me, are cheap, simple fixes. You should never have posters for conferences that have all males. That costs you almost no money. So I think there are lots of things you can do that dont require major investments that send signals that are positive.

Q: They say that science is at least partly about failure and learning from failure. Do you have advice on how you deal with failure?

A: Its very hard to say to someone, Look, its just not working. So I try to do it early and then say, Lets move on. Why dont you work on this thing that is working for a while so you can feel what its like to have something work, and then maybe thatll get you a paper or chapter in your thesis. Then you can go back to something riskier.

But at the same time, I like to encourage people to be risk takers, because if you dont take risks, youre not going to get anywhere. So there has to be some balance. I will say its the thing I most lose sleep over. Forget not getting grants and all that. Its the people you worry about you want everyone to succeed. At my stage, this is not about me anymore. Its about them.

Read the original:
Harvard's Pamela Silver recalls journey from Silicon Valley to synthetic biology - Harvard Gazette

Dragonfly Therapeutics Announces Head of Biology – Canada NewsWire (press release)

Dragonfly announces that Dr. Ann Cheung will become its Head of Biology, leading critical development of the company's novel Natural Killer cell-based immunotherapies.

CAMBRIDGE, Mass., May 16, 2017 /CNW/ --Dragonfly Therapeutics, Inc. ("Dragonfly"), today announced that Dr. Ann Cheung will become its Head of Biology, directing key immuno-oncology functions for the development of its novel Natural Killer ("NK") cell-based therapies.

"Ann is an outstanding scientist," said Dragonfly co-founder and head of the Koch Institute for Integrative Cancer Research at MIT, Dr. Tyler Jacks. "After working with her for six years in MIT labs earlier in her career, I know that she will bring immense creativity, innovation, experience and drive to her important role as Dragonfly's Head of Biology.

As Dragonfly's Head of Biology, Dr. Cheung manages all immune-oncology functions for the development of the company's proprietary NK cell engagers, directing research into NK cell biology and mechanism of action. She works closely with the Head of Biologics, Dr. Asya Grinberg.

At the Jacks lab, Ann studied the interface of between lung tumors and anti-cancer T cells, and initiated the group's forays into cancer immunology. Ann's postdoctoral work was at Caltech, and included a collaboration with Drs. Antoni Ribas and Nobel Laureate David Baltimore to assess T cell multi-functionality in a clinical trial using engineered T cells for immunotherapy in advanced melanoma patients. Ann received her undergraduate degree from Brown University with a concentration in Biochemistry and Molecular Biology, and received her Ph-D from the MIT Department of Biology.

About DragonflyDragonfly Therapeutics harnesses its novel TriNKET technology to develop drugs that leverage the power of the innate immune system to provide breakthrough cancer treatments for patients.

For more information visit: http://www.dragonflytx.com, https://www.facebook.com/dragonflytherapeutics/, https://twitter.com/dragonflytx

Media Contact: Maura McCarthy 617-588-0086 x702 maura@dragonflytx.com

SOURCE Dragonfly Therapeutics, Inc.

See the original post here:
Dragonfly Therapeutics Announces Head of Biology - Canada NewsWire (press release)

ABC fall 2017 lineup: ‘Grey’s Anatomy’ spinoff, ‘Good Doctor,’ more – Newsday

ABC will spin off series from three franchises next season Greys Anatomy, The Bachelor and Dancing With the Stars and add yet another Marvel-based drama, the network announced Tuesday.

The Greys spinoff will be set in a Seattle firehouse, with characters introduced on the flagship series next season. In addition, The Bachelor Winter Games will cast past contestants in a series with winter-themed athletic challenges including the toughest sport of all, love.

Then this: Dancing With the Stars Junior will pair celebrity kids and kids of celebrities with professional junior ballroom dancers. No airdates set, but the reality series will premiere next year.

ABC executives also said the network will air a live comedy special produced by Jimmy Kimmel and Justin Theroux featuring comics reading scripts from classic sitcoms.

Heres the fall lineup:

Monday: Dancing With the Stars (8); The Good Doctor (10), with Freddie Highmore as a surgeon with autism and savant syndrome.

Tuesday: The Middle (8); Fresh Off the Boat (8:30); black-ish (9); The Mayor (9:30), about a rapper (Brandon Micheal Hall) who becomes mayor (its produced by Daveed Diggs of Hamilton); The Gospel of Kevin (10), with Jason Ritter and JoAnna Garcia Swisher, about a guy on a mission to save the world.

Wednesday: The Goldbergs (8); Speechless (8:30); Modern Family (9); American Housewife (9:30); Designated Survivor (10).

Thursday: Greys Anatomy (8); Scandal (9); How to Get Away With Murder (10).

Friday: Once Upon a Time (8); Marvels Inhumans (9), about Black Bolt (Anson Mount) he with the very loud voice and his family of Inhumans; 20/20 (10).

Saturday: College football

Sunday: Americas Funniest Home Videos (7); To Tell the Truth (8); Shark Tank (9); Ten Days in the Valley (10), with Kyra Sedgwick as a news producer whose child goes missing.

Read this article:
ABC fall 2017 lineup: 'Grey's Anatomy' spinoff, 'Good Doctor,' more - Newsday

StaTuesday: Anatomy of Twins’ home run streak – FOXSports.com

The Minnesota Twins might not be baseballs most powerful team, but they might be the most efficient.

The Twins are tied for 21st in the majors with 40 home runs in their 32 games. However, Minnesota is bunching those homers together.

In those 32 games, the Twins have hit at least one home run in 24 of them (75 percent). In addition, Minnesota is currently on a streak of hitting a home run in a 15 consecutive games, which is one shy of the club record set in 1979.

Minnesota had multiple homer six times during that 79 run; this year, just four times in the 15 games.

Before this season, no Twins team had a streak as long as 12 games since 2002.

The 1979 team had eight player home during their 16-game streak. Catcher Butch Wynegar his five of his seven homers that season in that span while FOX Sports North announcer Roy Smalley smashed six.

This years Twins team has seen 10 different players homer during the 15-game streak, including one by a player no longer with the franchise. Joe Mauers walk-off winner on May 5 against Boston was the only homer that game.

If this years Minnesota team is going to tie the franchise record for consecutive games with a home run, itll have to avoid a bit of a coincidence. That streak in 1979 just happened to end at home and wait for it on May 16. (We also will hate to point out that Colorados starter Tuesday is rookie Kyle Freeland, who has allowed just one homer in 40 innings.)

Dave Heller is the author of Ken Williams: A Slugger in Ruths Shadow, Facing Ted Williams Players From the Golden Age of Baseball Recall the Greatest Hitter Who Ever Lived and As Good As It Got: The 1944 St. Louis Browns

Go here to see the original:
StaTuesday: Anatomy of Twins' home run streak - FOXSports.com

Home | Penn Medicine Translational Neuroscience Center …

As a Center within the Perelman School of Medicine (PSOM) at the University of Pennsylvania, the Penn Medicine Translational Neuroscience Center (PTNC) is dedicated to accelerating and translating discoveries to transform the prevention, diagnosis and treatment of neuropsychiatric and neurological conditions. This year, we held an inaugural PTNC scientific retreat that included 30 basic and clinical neuroscientists across 16 departments and 4 schools at Penn.Generating a collective vision for the neurosciences, the group identified key research priorities that have the greatest potential to transform patient care.Based on this discussion, we identified two thematic areas that provided the focus for the first round of requests for applications a new Translational Neuroscience Initiative(TNI): (1) modulation of neural circuits for preventive health behaviors or recovery from neuropsychiatric or neurological disease, and (2) neuroimmune mechanisms and treatment for neuropsychiatric or neurological disease.In addition, the PTNC is working closely with Penns new Institute for Bioinformaticsto create a neuro-informatics infrastructure to support translational research, and is developing a Translational Neuroscience Pipeline that facilitates industry partnerships. PTNC is also partnering with the MahoneyInstitute for Neurosciences to enhance integration and synergies across the neurosciences at Penn. We welcome faculty within Penns neuroscience community to become members of the PTNC, and look forward to working with you to promote translational neuroscience research at Penn.

Go here to read the rest:
Home | Penn Medicine Translational Neuroscience Center ...

The Transit Factor: Driving momentum in outdoor with neuroscience – AdNews

What exactly happens to our brain when we see something move? Well, evolution tells us that to survive we pay attention to anything in our vision that moves. Its innate. And its part of the reason why advertising that moves, while you are moving about your city, town, daily commute, life, is that much more powerful at retaining memory.

As leaders in the outdoor media space, APN Outdoor have no peer in market when it comes to transit advertising and have known for many years that it works.

People see it multiple times a week, it delivers incremental reach, audiences are continuously growing and advertisers love it. However they wanted to reinforce these attributes and prove to advertisers why.

Why does Transit perform so highly on measures of recall, exposure and effectiveness?

In a research collaboration with Neuro-Insight, APN Outdoor paired ethnography, which is the study of observing real people in their real world, with neuroscience, studying the brains reaction to stimulus.

The objective was to compare and identify the key differences between static and moving advertising. As a result they discovered the formula behind the power of movement the Transit Factor.

Movement increases memory encoding in the brain and memory encoding increases ad effectiveness. And transit advertising is 20% higher than all other outdoor formats when it comes to memory encoding.

Key findings:

The study analysed over four billion data points, with subjects exposed to moving and static ads, and the only relative difference was movement. All of the results are being presented around the country as part of a national roadshow. Get in touch with APN Outdoor to learn more about it or send any questions about semiotics, ethnography or the neuroscience to Neuro-Insight and The Lab.

Have something to say on this? Share your views in the comments section below. Or if you have a news story or tip-off, drop us a line at adnews@yaffa.com.au

Sign up to the AdNews newsletter, like us on Facebook or follow us on Twitter for breaking stories and campaigns throughout the day. Need a job? Visit adnewsjobs.com.au.

More:
The Transit Factor: Driving momentum in outdoor with neuroscience - AdNews

Making Neuroscience Fun – NY City Lens

Neuroscience is complex, but a group of scientists and doctors tried to make it easy to understand at Mount Sinai Hospital on May 5.

In celebration of Brain Awareness Week, organizations include Mentoring in Neuroscience Discovery at Sinai, the Friedman Brain Institute, and the Center for Excellence in Youth Education at Mount Sinai hosted its 5th Annual Brain Awareness Fair for local students, their parents, and community members to help them learn about neuroscience. The event took place at Mount Sinai Hospital.

(Photo by Zhiming Zhang/ NY City Lens)

There were more than 30 booths with games and informational activities on topics like memory, perception, traumatic brain injury, and more. More than 500 people filled the decorated Guggenheim Pavilion of the hospital to interact with scientists and doctors who study and treat the brain.

(Photo by Zhiming Zhang/ NY City Lens)

One of the most popular booths was a 3D Virtual Reality Brain Surgery Simulator, shaped like a colorful, giant brain. The exhibit showed visitors what its like to perform brain surgery on patients. Holly Oemke, program manager of Neurosurgery Simulation Core, said the 3D prints children received were examples of real people. The prints aimed to show children how patients brains look like, in order to help them learn the information better.

I hope that the kids learn about more than just what a normal brain does, but the intricacies within the head, Omeke said. More importantly, be excited by science.

(Photo by Zhiming Zhang/ NY City Lens)

Many children who attended did get excited. It was Jonathan Vasquezs first time attending the Brain Awareness Fair. The 10-year-old fifth-grader from PS 171 said the experience he had at the virtual reality booth was his favorite because it made him feel like that he was in a brain, which he found, in his words, cool. He said he would recommend this event to his friends. Theres a lot of cool science stuff, he said. You can go VR, you can control someone else, and you get candy.

Another popular booth was something that involved of all things, dropping eggs, wrapped in plastic, from a three-foot height. The activity was intended to help visitors learn how the parts of the body protect the brain.

(Photo by Zhiming Zhang/ NY City Lens)

Lucy Bicks, 25, a volunteer at the Egg Drop booth, said the visitors are instructed to think of the eggs as their brains and told to construct a helmet with packing materials. After finishing the helmet, they can test its effectiveness by dropping the wrapped egg to the ground to demonstrate the importance of wearing a helmet to prevent people from traumatic brain injury and concussion.

We hope that the people really understand the importance of protecting their brains through helmets, and also the dangers of concussion, Bicks said.

(Photo by Zhiming Zhang/ NY City Lens)

The event was originally scheduled to take place during Brain Awareness Week in March but had to be rescheduled due to inclement weather.

Alyson Davis, program director for Mount Sinais Youth Education Center, said that she hopes that people, especially kids, will be fearless when it comes to science after attending this fair. We really want them to experience something hands-on and first-hand, and thats what gets them excited, Davis said. Hopefully, these kids are the future graduates of our medical schools and graduate schools.

See more here:
Making Neuroscience Fun - NY City Lens

Yawning May Promote Social Bonding Even Between Dogs And … – NPR

Turns out that humans aren't the only animals that contagiously yawn. iStockphoto hide caption

Turns out that humans aren't the only animals that contagiously yawn.

Bears do it; bats do it. So do guinea pigs, dogs and humans. They all yawn. It's a common animal behavior, but one that is something of a mystery.

There's still no consensus on the purpose of a yawn, says Robert Provine, professor of psychology and neuroscience at the University of Maryland, Baltimore County. Provine has studied what he calls "yawn science" since the early 1980s, and he's published dozens of research articles on it. He says the simple yawn is not so simple.

"Yawning may have the dubious distinction of being the least understood common human behavior," Provine says.

There are many causes for yawning. Boredom, sleepiness, hunger, anxiety and stress all cause changes in brain chemistry, which can trigger a spontaneous yawn. But it's not clear what the yawn accomplishes. One possibility is the yawn perks you up by increasing heart rate, blood pressure and respiratory function.

"[Yawning] stirs up our physiology and it plays an important role in shifting from one state to another," Provine says.

When violinists get ready to go on stage to play a concerto, they often yawn, says Provine. So do Olympians right before a competition, or paratroopers getting ready to do their first jump. One study found that yawning has a similar impact on the brain as a dose of caffeine.

But not all yawn researchers agree with this theory.

"No specific arousing effect of yawning on the brain could be observed in at least five studies," says Adrian Guggisberg, a professor in the department of clinical neurosciences at the University of Geneva.

Guggisberg and fellow researchers reviewed several theories of yawning and concluded that the arousal theory lacks evidence. What they did find were several studies that show yawning is highly contagious among humans, suggesting that "yawns might have a social and communicative function," Guggisberg said in an e-mail.

Looking at yawns, hearing yawns, thinking about yawns or talking about yawns will likely trigger a contagious response. Contagious yawning may have evolved in early humans to boost social bonding, according to Provine. A good group yawn could serve to perk everyone up to be more vigilant about danger, he says.

Another piece of evidence backing up the social bonding theory of yawning is a 2011 study by Ivan Norsicia and Elisabetta Palagi that found people are more likely to copy a yawn if they know the person who is yawning. A stranger's yawn is less likely to trigger a contagious response. And while babies yawn spontaneously, children don't engage in contagious yawning until about age 4 around the same time they're becoming more socially connected.

Now, what about other animals? We know that all vertebrates, critters with backbones, yawn spontaneously. But very few yawn contagiously.

"Until the last few years, the feeling was that contagious yawning was unique to humans," Provine says.

But recently, two more species have been added to the list of contagious yawners: dogs and chimpanzees. When two groups of chimpanzees were shown videos of familiar and unfamiliar chimps yawning, the group watching the chimps they knew engaged in more contagious yawning. This study, by Matthew Campbell and Frans de Waal, supports the theory that yawning plays a role in the evolution of social bonding and empathy.

And dogs not only catch each others' yawns, they are susceptible to human yawning as well. In one study, 29 dogs watched a human yawning and 21 of them yawned as well suggesting that interspecies yawning could help in dog-human communication.

Go here to see the original:
Yawning May Promote Social Bonding Even Between Dogs And ... - NPR

Newman Ferrara LLP Announces Corporate Governance Investigation of NewLink Genetics Corporation – NLNK – Business Wire (press release)

NEW YORK--(BUSINESS WIRE)--Newman Ferrara LLP announced today that the firm is conducting an investigation on behalf of shareholders of NewLink Genetics Corporation (NewLink or the Company) (NASDAQ:NLNK) into potential breaches of fiduciary duty by the Companys Board of Directors (the Board).

NewLink, headquartered in Ames, Iowa, is a biopharmaceutical company. Despite the Companys low market capitalization and increasing investment in research and development since it became a public company in 2011, the Board continues to make decisions, without shareholder approval, that significantly diminish shareholder value and do not benefit the Company. Based on this, it appears the Board lacks the ability to fairly assess and oversee the Companys direction and leadership.

Current NewLink stockholders seeking more information on this matter are invited to contact Newman Ferrara attorneys Jeffrey Norton (jnorton@nfllp.com) or Roger Sachar, Jr. (rsachar@nfllp.com) to discuss this investigation and their rights.

Newman Ferrara maintains a multifaceted practice based in New York City with attorneys specializing in complex commercial and multi-party litigation, securities fraud and shareholder litigation, consumer protection, civil rights, and real estate. For more information, please visit the firm website at http://www.nfllp.com.

More here:
Newman Ferrara LLP Announces Corporate Governance Investigation of NewLink Genetics Corporation - NLNK - Business Wire (press release)